A new study ay National Cancer Institute says men with jobs that expose them to high levels of sunlight are less likely to develop kidney cancer than those with little or no sunlight exposure at work.
Vitamin D is metabolized and most active within the kidneys and previuos research suggests that vitamin D, which is obtained […]

continue reading from " Sunlight may help protect men from kidney cancer "

A recent study at Kyoto Prefectural University of Medicine, Japan, suggests that for men with type 2 diabetes, a cell type linked to allergic inflammation is closely linked to a key indicator of diabetic kidney disease (nephropathy).
Previous studies have suggested that patients with asthma and other allergic diseases are at increased risk of heart disease. Heart […]

continue reading from " Male diabetics with allergies close linked to kidney disease "

According to a paper being presented at the American Society of Nephrology’s 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania, kidney stones may damage the kidneys and lead to chronic kidney disease (CKD).
In extreme cases, individuals with CKD caused by kidney stones may even need dialysis or kidney transplants.
Kidney stones lead to CKD in […]

continue reading from " Kidney stones may increase risk for chronic kidney disease "

A new study at University Hospital Basel , Switzerland, says women who receive kidneys from males have a higher rate of graft failure than other donor-recipient combinations, and gender should be considered when choosing donor matches.
Compared with all other gender combinations, transplantation of male donor kidneys into female patients was associated with an 8 percent […]

continue reading from " Gender should be considered in kidney transplant "

A study at Stanford University School of Medicine say that a greater percentage of patients than previously thought may develop heart failure when taking the breakthrough cancer drug Sutent.
The study author reports that data support a role for routine cardiac monitoring for patients receiving sunitinib [Sutent] and careful study of adverse cardiac events in future […]

continue reading from " Kidney Cancer Drug Linked to Higher Rate of Heart Problems "

According to a study conducted in Germany, analgesics other than phenacetin are not connected with an increased risk of developing end-stage renal disease (ESRD) at a relatively young age.
The researchers reported their findings in the online journal BioMedCentral-Nephrology.

continue reading from " Painkillers Do Not Raise Kidney Disease Risk "

A new research at the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) suggests that children and teens diagnosed with type 2 diabetes are five times more likely to develop kidney disease later in life than those who develop diabetes as adults.
The findings underscore the importance of preventing — or at least […]

continue reading from " Childhood Diabetes Boosts Risk for Kidney Problems "

According to a new study conducted at the Charite Children’s Hospital in Berlin, Germany, high blood pressure and high lipid levels, as well as longer disease duration, elevated glucose (sugar) levels, and male gender, are all significant risk factors for kidney disease in patients with type 1 diabetes.
The team concludes that early diagnosis and prompt […]

continue reading from " Risk Factors for Type 1 Diabetes Identified "

Paracetamol (acetaminophen) is one of the drug widely used painkillers. A preliminary laboratory study published in the ACS’ Chemical Research in Toxicology journal suggests that people taking paracetamol should limit the intake of caffeine because the caffeine triples the amount of a toxic by-product created when the pain killer is broken down. The toxin is […]

continue reading from " Paracetamol (acetaminophen) with coffee lethal for liver "

A research at the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, USA, revealed that axitinib, an experimental drug, has potential to bring respite to patients with advanced kidney cancer even after their tumour stops to respond to the cutting edge therapy.
The researchers have demonstrated that the drug shrank tumours, and delayed the disease’s progression.
The […]

continue reading from " Experimental drug shrinks tumours in kidney cancer patients "